Press releases | UCB
UCB's Global Corporate Website

This section is intended for media and financial analysts

Search Press releases

11 Apr 2022

Disposal of own shares

Read More
1 Apr 2022

Disposal of own shares

Read More
1 Apr 2022

UCB Showcases Strength of Broad Neurology Portfolio at 74th American Academy of Neurology (AAN) Annual Meeting

Read More
28 Mar 2022

U.S. FDA Approves FINTEPLA® ▼(fenfluramine) Oral Solution for Treatment of Seizures Associated with Lennox-Gastaut Syndrome (LGS)

Read More
26 Mar 2022

New Long-Term Complete Skin Clearance Data for BIMZELX[®]▼ (bimekizumab) in Moderate to Severe Plaque Psoriasis Presented at the 2022 AAD Annual Meeting

Read More
25 Mar 2022

Disposal of own shares

Read More

Stay up-to-date on the latest news and information from UCB